The selective CDK2 inhibitor INX-315 has been given FDA fast track designation for use in CCNE1-amplified, platinum-resistant ...

Oncology nurses can encourage clinical trial enrollment for patients with anaplastic thyroid cancer, a rare and aggressive ...

The FDA has approved a ready-to-dilute, multi-dose formulation of thiotepa (Tepylute) for use in breast and ovarian ...

Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma ...

Nurse practitioners and physician assistants can advocate to play a number of roles in oncology research, including primary ...

AYA Cancer Awareness month offers an opportunity for nurses to go further in supporting AYAs with cancer.

Identity and Independence: Many AYAs are in a developmental stage where they are gaining autonomy. A cancer diagnosis can contribute to feeling less independent. Nurses and social workers can help AYA ...

Both those receiving either expected or less-than-expected starting dosages of ruxolitinib for myelofibrosis treatment ...